These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22174207)

  • 21. [Subclinical and clinical manifestations of atherosclerosis in antiphospholipid syndrome].
    Reshetniak TM; Seredavkina nV; Mach ES; Aleksandrova EN; Novikov AA; Cherkasova MV; Nasonov EL
    Ter Arkh; 2008; 80(10):60-7. PubMed ID: 19105418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistance to annexin A5 anticoagulant activity: a thrombogenic mechanism for the antiphospholipid syndrome.
    Rand JH; Wu XX; Quinn AS; Taatjes DJ
    Lupus; 2008 Oct; 17(10):922-30. PubMed ID: 18827057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of anti-annexin A5 in pathogenesis of hypercoagulable state in patients with antiphospholipid syndrome.
    Singh NK; Yadav DP; Gupta A; Singh U; Godara M
    Int J Rheum Dis; 2013 Jun; 16(3):325-30. PubMed ID: 23981755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Association between anti-phospholipid antibodies and thrombotic complications in systemic lupus erythematosus].
    Nojima J
    Rinsho Byori; 2003 Mar; 51(3):239-47. PubMed ID: 12707997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus.
    Asherson RA; Lioté F; Page B; Meyer O; Buchanan N; Khamashta MA; Jungers P; Hughes GR
    J Rheumatol; 1993 Feb; 20(2):284-8. PubMed ID: 8474066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiphospholipid antibody syndrome: the flow cytometric annexin A5 competition assay as a diagnostic tool.
    Tomer A; Bar-Lev S; Fleisher S; Shenkman B; Friger M; Abu-Shakra M
    Br J Haematol; 2007 Oct; 139(1):113-20. PubMed ID: 17854315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble adhesion molecules in pediatric rheumatic diseases.
    Bloom BJ; Miller LC; Blier PR
    J Rheumatol; 2002 Apr; 29(4):832-6. PubMed ID: 11950029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders.
    Brenner B; Tavori S; Lerner M; Tatarsky I; Lorber M
    Isr J Med Sci; 1992 Jan; 28(1):9-15. PubMed ID: 1733904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody-mediated interference with annexins in the antiphospholipid syndrome.
    Rand JH; Wu XX
    Thromb Res; 2004; 114(5-6):383-9. PubMed ID: 15507268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma levels of annexins IV and V in relation to antiphospholipid antibody status in women with a history of recurrent miscarriage.
    Ulander VM; Stefanovic V; Masuda J; Suzuki K; Hiilesmaa V; Kaaja R
    Thromb Res; 2007; 120(6):865-70. PubMed ID: 17363042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies.
    Horbach DA; van Oort E; Donders RC; Derksen RH; de Groot PG
    Thromb Haemost; 1996 Dec; 76(6):916-24. PubMed ID: 8972011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiphospholipid antibodies among anti-U1-70 kDa autoantibody positive patients with mixed connective tissue disease.
    Komatireddy GR; Wang GS; Sharp GC; Hoffman RW
    J Rheumatol; 1997 Feb; 24(2):319-22. PubMed ID: 9034990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of antiphospholipid antibody levels and type on thrombotic manifestations: results from the Serbian National Cohort Study.
    Stojanovich L; Markovic O; Marisavljevic D; Elezovic I; Ilijevski N; Stanisavljevic N
    Lupus; 2012 Mar; 21(3):338-45. PubMed ID: 21993381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of anti-cardiolipin antibodies and IVIg on annexin A5 binding to endothelial cells: implications for cardiovascular disease.
    Frostegård AG; Su J; von Landenberg P; Frostegård J
    Scand J Rheumatol; 2010; 39(1):77-83. PubMed ID: 20132075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Childhood-onset systemic lupus erythematosus: antiphospholipid antibodies in 37 patients and their first-degree relatives.
    Molta C; Meyer O; Dosquet C; Montes de Oca M; Babron MC; Danon F; Kaplan C; Clémenceau S; Castellano F; Levy M
    Pediatrics; 1993 Dec; 92(6):849-53. PubMed ID: 8233748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma annexin A5, anti-annexin A5 antibodies and annexin A5 polymorphism in Egyptian female patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Nasef A; Ibrahim M; Riad N; Mousa S
    Clin Lab; 2014; 60(1):133-7. PubMed ID: 24600987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiphospholipid antibodies in pediatric systemic lupus erythematosus.
    Seaman DE; Londino AV; Kwoh CK; Medsger TA; Manzi S
    Pediatrics; 1995 Dec; 96(6):1040-5. PubMed ID: 7491218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta 2 glycoprotein I and placental anticoagulant protein I in placentae from patients with antiphospholipid syndrome.
    La Rosa L; Meroni PL; Tincani A; Balestrieri G; Faden D; Lojacono A; Morassi L; Brocchi E; Del Papa N; Gharavi A
    J Rheumatol; 1994 Sep; 21(9):1684-93. PubMed ID: 7799350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome.
    Avcin T; Silverman ED
    Lupus; 2007; 16(8):627-33. PubMed ID: 17711899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Annexin A5 in cardiovascular disease and systemic lupus erythematosus.
    Cederholm A; Frostegård J
    Immunobiology; 2005; 210(10):761-8. PubMed ID: 16325495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.